What Geocann does

Geocann is a Fort Collins, Colorado-based cannabis biotechnology company founded in 2018 by Jesse Lopez that licenses patented drug delivery system technology to brand partners across the cannabis, nutraceutical, pharmaceutical, and consumer health industries. Its core asset is VESIsorb®, a multi-patented lipid-based self-assembling colloidal droplet delivery system (typically less than 100nm in diameter) that dramatically improves the bioavailability of poorly water-soluble phytocannabinoids and terpenes by mimicking the body's natural mixed micellar absorption pathway. Published peer-reviewed pharmacokinetic studies in Molecules demonstrate 440% increases in maximal plasma CBD concentration (Cmax) and 360% increases for BCP versus standard oil formulations, with the technology commercialized across 50+ formulations and 200 million+ consumer exposures globally since 2005 through an exclusive partnership with Vesifact AG (Baar, Switzerland). Complementary proprietary platforms include DPTechnology™ (transferrin-bound liposomal delivery) and the patent-pending VESIsorb® VEDD system for water-insoluble compounds.

Geocann monetizes through four revenue streams: (1) licensing and royalties on VESIsorb® formulations supplied to brand partners such as Sunderstorm (Kanha Nano gummies), Cronos Group (Lord Jones CBD Gel Capsules), and Cresco Labs (Good News gummies); (2) ingredient sales of full-spectrum hemp oil, water-soluble powder, distillate, and isolate in standard or VESIsorb® formats; (3) custom formulation services for private-label partners across capsules, tinctures, sublingual sprays, gummies, lozenges, chocolates, beverages, topicals, and animal nutrition; and (4) exclusive distribution agreements — notably Opticann for U.S. mass retail (CVS, Walgreens, Walmart, Costco) and Pathway Health for Canadian pharmacy channels covering 10,000+ pharmacies and 42,000+ pharmacists. The company operates four offices (Fort Collins HQ, Chicago, Corona, and Baar, Switzerland) with 11-50 employees, and is actively pursuing regulatory milestones including NSF International certification (achieved), FDA GRAS Notification, Novel Food application, and pharmaceutical-grade positioning via an FDA Drug Master File (DMF 036798) through its Averix Bio partnership.

The company is privately held with no institutional funding rounds disclosed in the available data. Its leadership team combines nutrition industry veterans (CEO Jesse Lopez, 40+ years; COO Sam Davidson) with deep pharmaceutical and drug delivery expertise (CSO Marc Weder, co-founder of Vesifact AG; Dr. Michael Davidson, founder of Corvidia Therapeutics, which was acquired by Novo Nordisk for $2.1B in 2020). Headcount is small (11-50), revenue is not publicly disclosed, and the operating model is capital-light licensing and B2B ingredient supply rather than direct-to-consumer manufacturing. Strategic positioning emphasizes clinical evidence (peer-reviewed PK studies, NSF certification, cGMP compliance) as the principal differentiator in a fragmented cannabis and nutraceutical ingredients market where bioavailability remains the dominant product performance bottleneck.

Name

Geocann

Legal name

Geocann

Website

https://geocann.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Geocann is a Fort Collins, Colorado-based cannabis biotechnology company that licenses patented VESIsorb® drug delivery technology to brand partners across cannabis, nutraceutical, pharmaceutical, and consumer health verticals, dramatically improving cannabinoid and terpene bioavailability through self-assembling colloidal droplets.

Ownership category

akta.pro rank

Product category

Cannabinoid Bioavailability Technology

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Hemp & CBD Product Wholesale Distribution (CRAOAIAG)

akta.pro secondary industries

Herbal & Botanical Supplements (CRADAGAD), CBD/Hemp Topicals & Beauty Retail (CRANAHAB)

Keywords

• Cannabinoid delivery systems
• Bioavailability technology
• Cannabis ingredient manufacturing
• Private label formulations
• Phytocannabinoid licensing

Headquarters

HQ city

Fort Collins

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Licensed Technology & Formulations: Geocann licenses its patented VESIsorb® drug delivery technology to brand partners for use in their cannabis products. Partners include Sunderstorm (Kanha Nano), Cronos (Lord Jones), Nestlé Health Science, and others. Revenue comes from licensing fees, royalties, and supply agreements.
2. Ingredient Sales: Sale of proprietary hemp-derived ingredients including full spectrum hemp oil (CBD), water-soluble powder (CBD), distillate (CBD or THC), and isolate (CBD or CBG). Products available in standard or patented VESIsorb® formulations.
3. Custom Formulation Services: Development and manufacturing of custom formulations for private label partners. Includes soft gel capsules, tinctures, sublingual sprays, gummies, lozenges, chocolates, beverages, topicals, and animal nutrition products.
4. Distribution Agreements: Strategic distribution agreements providing exclusive or semi-exclusive rights to market VESIsorb® formulated products. Includes agreements with Opticann for major retail chains (CVS, Walgreens, Rite-Aid, Kroeger, Walmart, Costco) and Pathway Health for Canadian pharmacy market.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Core offering

Geocann develops and licenses patented drug delivery system technologies, principally VESIsorb, a self-assembling colloidal droplet lipid-based platform that dramatically improves the bioavailability of poorly absorbed cannabinoids, terpenes, and flavonoids. The company supplies proprietary hemp- and cannabis-derived base ingredients (full spectrum hemp oil, water soluble powder, distillate, isolate in CBD/THC/CBG forms) and offers custom private-label formulation services for soft gels, tinctures, sublingual sprays, gummies, lozenges, chocolates, beverages, topicals, and animal nutrition products to brand partners worldwide.

Product overview

Geocann is a global cannabis organization that combines clinically-researched cannabinoids and terpenes with technologically-advanced drug delivery system technologies (VESIsorb, DPTechnology, VESIsorb VEDD) that increase absorption and bioavailability for maximum health benefits. The company offers a comprehensive portfolio of base ingredients (full spectrum hemp oil, water soluble powder, distillates, isolates in CBD/CBG/THC variants), product applications (soft gel capsules, tinctures, sublingual sprays, gummies, lozenges, chocolates, topicals, beverages, animal nutrition, coffee, and condition-specific formulas), and branded ingredients (HempChoice, BioTHC). Geocann also provides private label custom formulation services and supports partner brands including TheraHemp, Kanha Nano, TruEase, BETACAN, Good News Gummies, Lord Jones, and others, all leveraging the proprietary VESIsorb drug delivery technology platform for enhanced bioavailability.

Differentiator

Problem solved

Functional benefit

Brands

• VESIsorb: Patented drug delivery system technology for improving bioavailability of cannabinoids and terpenes
• DPTechnology
• VESIsorb VEDD Delivery System
• HempChoice
• BioTHC

Products and services

• VESIsorb Drug Delivery Technology
• Cannabinoid Base Ingredients
• Custom Formulation Services (Private Label)
• HempChoice Branded Hemp Extract
• BioTHC Branded THC Ingredient
• DPTechnology
• VESIsorb VEDD Delivery System

Quantifiable outcome

• 440% increase in maximal plasma CBD concentration (Cmax) with VESIsorb vs MCT oil formulation
• +8 more outcomes

Named customers14 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

18 partnerships are on record, tiered major and core.

• THCG Group Ltd.majorChannel Partner/ Reseller/ Distributor · 8 December 2022Thailand-based vertically integrated medical cannabis license holder managing cultivation, production, and distribution of Kanha edibles powered by VESIsorb for Thailand and Asia market. First North American cannabis edibles brand to launch in Asia.
• Cronos Group (Lord Jones)coreStrategic or Co-development Partner · 27 June 2022Partnership with Cronos Group Inc. (NASDAQ: CRON) for launch of Lord Jones CBD Gel Capsules utilizing advanced VESIsorb delivery system. First of expected range of products leveraging the technology for better bioavailability and faster absorption.
• Averix BiocoreStrategic or Co-development Partner · 13 April 2022Strategic partnership for exclusive distribution of pharmaceutical API phytocannabinoid ingredients in South American marketplace. Averix Bio maintains 21 CFR Part 210/211, ICH Q7, 200-level cGMP compliance and FDA Drug Master File (DMF 036798). Alliance focuses on bridging gap with pharmaceutical sector.
• TheralogixcoreStrategic or Co-development Partner · 31 March 2022Launched TheraHemp - NSF International certified CBD and BCP softgel formulation using clinically proven VESIsorb® delivery system. Delivers 20mg CBD and 8mg BCP per softgel. First CBD product with a delivery system technology to pass NSF's rigorous safety testing protocol.
• Pathway Health Corp.coreChannel Partner/ Reseller/ Distributor · 27 January 2021Exclusive distribution of VESIsorb® formulated medical cannabis products to leading Canadian pharmacies through PHC's retail pharmacy partners. PHC operates largest chronic pain telehealth network in Canada with agreements with national pharmacy chains. Partnership includes pharmacist education programs and patient fulfillment.
• Nestlé Health Science (Atrium Innovations)coreStrategic or Co-development Partner · 10 September 2020European expansion of hemp products formulated with VESIsorb® under Pure Encapsulations® brand. First large-scale production completed using European resources from Slovenia (cultivation/extraction) to Switzerland (soft gel production). Also markets under Douglas Laboratories® and Genestra Brands®.
• Cresco Labs (Good News)majorStrategic or Co-development Partner · 10 September 2020Launch of fast-acting gummy powered by VESIsorb delivery system under Good News brand. Cresco Labs is one of the largest publicly traded, vertically integrated multistate cannabis operators in the industry.
• OpticanncoreChannel Partner/ Reseller/ Distributor · 6 August 2020Exclusive distribution agreement for VESIsorb® formulated CBD and CBG products to major U.S. retailers including CVS, Walgreens, Rite-Aid, Kroeger, Walmart, and Costco. Agreement includes combination of cash, equity, and royalty payments. Opticann founded by former MedReleaf executives.
• SunderstormcoreStrategic or Co-development Partner · 1 September 2019Strategic partnership bringing VESIsorb® formulated cannabis products to new consumers through Kanha Nano brand. Kanha Nano launched in 2019 and became #1 selling gummy in California within months. Revenue increased over 300%. National expansion to Colorado and international expansion to Thailand underway.
• Vesifact AGcoreTechnology or Integration · 1 January 2005Longstanding partnership since 2005 with Vesifact AG (Zürich/Baar, Switzerland), the global pioneer in drug delivery system solutions. Geocann's leadership team has worked with Vesifact since 2005, successfully commercializing 50+ VESIsorb® formulations across all six continents. Co-founder Marc Weder is co-founder of Vesifact AG.
• SpritzigmajorStrategic or Co-development PartnerWorld's most science-backed CBD beverage with 10mg CBD from broad spectrum hemp extract, powered by VESIsorb® delivery system for optimal absorption and fast-acting wellness benefits in ready-to-drink format.
• VerséamajorStrategic or Co-development PartnerFirst VESIsorb formulated product from Verséa is CBD oral spray available in 600mg, 900mg, 1200mg, and 1500mg sublingual applications. Companies look forward to collaborating on innovative products and formulations.
• Health in HarmonymajorStrategic or Co-development PartnerPurpose-driven brand partnership launching 15 science-backed formulations including condition-specific nutraceuticals, topicals, and wellness beverages for health conscious consumers around the world.
• Mary Jane's MedicinalsmajorStrategic or Co-development PartnerSuper Strength Nano Salve combines 500mg THC and 500mg CBD with VESIsorb® for dramatically improved dermal penetration, permeation, and time of onset for minor aches and pains.
• TruGen3majorStrategic or Co-development PartnerTruEase product loaded with 25mg CBD formulated with VESIsorb® colloidal delivery system for optimal absorption. Introduced to thousands of healthcare professionals in North America.
• OnnitmajorStrategic or Co-development PartnerTotal Hemp powered by VESIsorb® as Onnit's first CBD product. One of the most recognized health and wellness lifestyle brands globally with distribution across multiple retail and e-commerce channels.
• UpSide EdiblesmajorStrategic or Co-development PartnerOrganic fruits and Belgian chocolate infused with CBD or THC, formulated with VESIsorb® for quicker onset and increased quality of psychoactivity. Available at 75+ California dispensaries.
• BETACANmajorStrategic or Co-development PartnerMost science-backed CBD plus BCP softgel with 25mg CBD and 12mg BCP per capsule powered by VESIsorb®. Most rigorously tested CBD product on market with stability data, toxicity data, and pharmacokinetic data supporting claims.

Scale indicators25 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• MediPharm Labs: MediPharm Labs is a cannabis-focused contract manufacturer specializing in GMP-certified extraction and formulation. Comparable as a B2B cannabis formulation peer, though with less differentiated proprietary drug delivery IP than Geocann's VESIsorb®.
• cbdMD: cbdMD is a publicly traded CBD consumer brand offering tinctures, gummies, topicals, and pet products. Comparable as a downstream customer profile for Geocann's VESIsorb®-formulated ingredients and as a peer in the premium CBD positioning category.
• Neptune Wellness Solutions: Neptune Wellness is a B2B-focused health and wellness company producing cannabis and nutraceutical ingredients. Comparable to Geocann as an ingredient/formulation supplier serving brand customers, though Neptune focuses more on extraction infrastructure than proprietary drug delivery.
• Elixinol Wellness: Elixinol is a global hemp-CBD wellness company selling branded products across multiple channels. Comparable to Geocann's downstream brand partners in the premium CBD positioning category and to the consumer-facing side of the cannabis wellness market.
• Charlotte's Web Holdings: Charlotte's Web is a leading CBD wellness brand with full-spectrum hemp extract products. Comparable to Geocann's downstream branded partners as a consumer-facing hemp-CBD company, though operating a vertically integrated cultivation and product model rather than a technology licensing model.

Broad incumbents

• Canopy Growth Corporation: Canopy Growth is one of the largest global cannabis companies with a portfolio of branded consumer and medical products. Comparable as a broad incumbent that could absorb Geocann's formulation technology across its CBD and THC product lines.
• Tilray Brands: Tilray is a global cannabis lifestyle and consumer packaged goods company. Comparable as a broad incumbent operating across cannabis cultivation, branded products, and beverages — the kind of large partner Geocann could supply VESIsorb® formulations to as it expands.
• Cronos Group: Cronos Group is a NASDAQ-listed global cannabinoid company (Lord Jones brand). Both a customer of Geocann (Lord Jones CBD Gel Capsules) and a broadly comparable peer operating across cultivation, production, and branded cannabis products.

Direct peers

• Lexaria Bioscience: Lexaria Bioscience develops DehydraTECH, a lipid-based drug delivery technology for cannabinoids and other actives. It is the closest direct competitor to Geocann's VESIsorb® platform, pursuing the same bioavailability value proposition with patented formulation IP.

Others

• Vesifact AG: Vesifact AG is a Swiss drug delivery company (founded 1987, spun out of ETH Zurich) that owns the VESIsorb® technology licensed to Geocann. Listed as 'Others' because it is simultaneously a strategic supplier, co-founder's prior venture, and the underlying IP holder — making it more ecosystem-enabling than directly competitive.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UClWAy2GUjSCeYeNVQqOltjg
• LinkedInlinkedin.com/company/geocann
• Facebookfacebook.com/GEOCANN

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Geocann